Why did I choose diagnostics?
I am an optimist. I see possibility in everything we do. Today we are delivering clinical utility—real value—by changing clinical practice.
Real People,
Real Science,
Real Answers.
Chief Executive Officer and
Chairman of the Board
This is the Age of Evidence.
Where a new definition of diagnostic truth is changing patient care as we know it. Where physicians and patients can now benefit from the evolution of healthcare and know, by design, the answers they seek.

Veracyte gives patients a clearer path for the future.

We are leading in the Age of Evidence.
our impact
The Age
of Evidence
Veracyte's genomic tests have the potential to save billions of dollars each year in unnecessary surgery costs.
Learn More >
Now Covered by Medicare
Genomic test is first to gain Medicare coverage for use in lung cancer screening and diagnosis.
learn more >

latest news
news and updates
Mar 23, 2017
Veracyte Announces that Multiple Studies Supporting Clinical Utility of Its Afirma® Gene Expression Classifier To Be Presented at ENDO 2017

learn more >
Mar 1, 2017
Veracyte Announces Fourth Quarter and Full-Year 2016 Financial Results, Provides 2017 Financial Outlook

learn more >
Feb 28, 2017
Veracyte Announces Executive Promotions

learn more >